Ding ST - Search Results

1

A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor.

Xing ND, Ding ST, Saito R, Nishizawa K, Kobayashi T, Inoue T, Oishi S, Fujii N, Lv JJ, Ogawa O, Nishiyama H. Xing ND, et al. Among authors: ding st. Asian J Androl. 2011 Mar;13(2):236-41. doi: 10.1038/aja.2010.171. Epub 2011 Feb 7. Asian J Androl. 2011. PMID: 21297652 Free PMC article.

2

Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells through p38 activation.

Matsui Y, Watanabe J, Ding S, Nishizawa K, Kajita Y, Ichioka K, Saito R, Kobayashi T, Ogawa O, Nishiyama H. Matsui Y, et al. BJU Int. 2010 Feb;105(4):558-64. doi: 10.1111/j.1464-410X.2009.08732.x. Epub 2009 Jul 6. BJU Int. 2010. PMID: 19583730

3

A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor.

Ding S, Nishizawa K, Kobayashi T, Oishi S, Lv J, Fujii N, Ogawa O, Nishiyama H. Ding S, et al. J Urol. 2010 Sep;184(3):1175-81. doi: 10.1016/j.juro.2010.04.073. Epub 2010 Jul 21. J Urol. 2010. PMID: 20663523

4

Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma.

Ding S, Xing N, Lu J, Zhang H, Nishizawa K, Liu S, Yuan X, Qin Y, Liu Y, Ogawa O, Nishiyama H. Ding S, et al. Int J Urol. 2011 Jun;18(6):432-8. doi: 10.1111/j.1442-2042.2011.02751.x. Epub 2011 Mar 30. Int J Urol. 2011. PMID: 21449971

5

The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.

Sun D, Lu J, Ding K, Bi D, Niu Z, Cao Q, Zhang J, Ding S. Sun D, et al. Med Oncol. 2013 Mar;30(1):476. doi: 10.1007/s12032-013-0476-0. Epub 2013 Feb 1. Med Oncol. 2013. PMID: 23371254

6

Eg5 inhibitor, a novel potent targeted therapy, induces cell apoptosis in renal cell carcinoma.

Ding S, Zhao Z, Sun D, Wu F, Bi D, Lu J, Xing N, Sun L, Wu H, Ding K. Ding S, et al. Tumour Biol. 2014 Aug;35(8):7659-68. doi: 10.1007/s13277-014-2022-x. Epub 2014 May 7. Tumour Biol. 2014. PMID: 24801905

7

A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.

Sun L, Lu J, Niu Z, Ding K, Bi D, Liu S, Li J, Wu F, Zhang H, Zhao Z, Ding S. Sun L, et al. PLoS One. 2015 Dec 10;10(12):e0144484. doi: 10.1371/journal.pone.0144484. eCollection 2015. PLoS One. 2015. PMID: 26658059 Free PMC article.

8

Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.

Wang Z, Liu S, Ding K, Ding S, Li C, Lu J, Gao D, Zhang T, Bi D. Wang Z, et al. Tumour Biol. 2016 Nov;37(11):15133-15143. doi: 10.1007/s13277-016-5395-1. Epub 2016 Sep 27. Tumour Biol. 2016. PMID: 27677286

9

Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.

Liu S, Gao M, Wang X, Ding S, Lv J, Gao D, Wang Z, Niu Z. Liu S, et al. Oncotarget. 2016 Nov 29;7(48):79141-79153. doi: 10.18632/oncotarget.13003. Oncotarget. 2016. PMID: 27816967 Free PMC article.

10

HCRP1 regulates proliferation, invasion, and drug resistance via EGFR signaling in prostate cancer.

Sun L, Lü J, Ding S, Bi D, Ding K, Niu Z, Liu P. Sun L, et al. Biomed Pharmacother. 2017 Jul;91:202-207. doi: 10.1016/j.biopha.2017.04.040. Epub 2017 Apr 28. Biomed Pharmacother. 2017. PMID: 28458158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters